TRxADE HEALTH (MEDS) Competitors $7.58 -0.55 (-6.77%) (As of 12/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends MEDS vs. HYFM, SAG, BANL, GDC, LTCH, COSM, TAIT, GWAV, HWH, and EDUCShould you be buying TRxADE HEALTH stock or one of its competitors? The main competitors of TRxADE HEALTH include Hydrofarm Holdings Group (HYFM), SAG (SAG), CBL International (BANL), GD Culture Group (GDC), Latch (LTCH), Cosmos Health (COSM), Taitron Components (TAIT), Greenwave Technology Solutions (GWAV), HWH International (HWH), and Educational Development (EDUC). These companies are all part of the "wholesale" industry. TRxADE HEALTH vs. Hydrofarm Holdings Group SAG CBL International GD Culture Group Latch Cosmos Health Taitron Components Greenwave Technology Solutions HWH International Educational Development Hydrofarm Holdings Group (NASDAQ:HYFM) and TRxADE HEALTH (NASDAQ:MEDS) are both small-cap basic materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, earnings, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and media sentiment. Is HYFM or MEDS more profitable? Hydrofarm Holdings Group has a net margin of -32.18% compared to TRxADE HEALTH's net margin of -149.81%. Hydrofarm Holdings Group's return on equity of -19.57% beat TRxADE HEALTH's return on equity.Company Net Margins Return on Equity Return on Assets Hydrofarm Holdings Group-32.18% -19.57% -10.92% TRxADE HEALTH -149.81%-196.79%-112.21% Which has better valuation & earnings, HYFM or MEDS? TRxADE HEALTH has lower revenue, but higher earnings than Hydrofarm Holdings Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHydrofarm Holdings Group$200.16M0.14-$64.81M-$1.41-0.43TRxADE HEALTH$7.45M1.43-$17.84MN/AN/A Does the MarketBeat Community favor HYFM or MEDS? Hydrofarm Holdings Group received 6 more outperform votes than TRxADE HEALTH when rated by MarketBeat users. However, 52.50% of users gave TRxADE HEALTH an outperform vote while only 46.55% of users gave Hydrofarm Holdings Group an outperform vote. CompanyUnderperformOutperformHydrofarm Holdings GroupOutperform Votes2746.55% Underperform Votes3153.45% TRxADE HEALTHOutperform Votes2152.50% Underperform Votes1947.50% Which has more volatility and risk, HYFM or MEDS? Hydrofarm Holdings Group has a beta of 1.91, meaning that its stock price is 91% more volatile than the S&P 500. Comparatively, TRxADE HEALTH has a beta of 2.32, meaning that its stock price is 132% more volatile than the S&P 500. Do insiders and institutionals hold more shares of HYFM or MEDS? 26.6% of Hydrofarm Holdings Group shares are owned by institutional investors. Comparatively, 5.7% of TRxADE HEALTH shares are owned by institutional investors. 4.8% of Hydrofarm Holdings Group shares are owned by insiders. Comparatively, 48.4% of TRxADE HEALTH shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts prefer HYFM or MEDS? Hydrofarm Holdings Group presently has a consensus target price of $0.70, indicating a potential upside of 15.70%. Given Hydrofarm Holdings Group's stronger consensus rating and higher probable upside, analysts clearly believe Hydrofarm Holdings Group is more favorable than TRxADE HEALTH.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hydrofarm Holdings Group 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00TRxADE HEALTH 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer HYFM or MEDS? In the previous week, Hydrofarm Holdings Group had 2 more articles in the media than TRxADE HEALTH. MarketBeat recorded 2 mentions for Hydrofarm Holdings Group and 0 mentions for TRxADE HEALTH. Hydrofarm Holdings Group's average media sentiment score of 0.97 beat TRxADE HEALTH's score of 0.00 indicating that Hydrofarm Holdings Group is being referred to more favorably in the media. Company Overall Sentiment Hydrofarm Holdings Group Positive TRxADE HEALTH Neutral SummaryHydrofarm Holdings Group beats TRxADE HEALTH on 10 of the 15 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get TRxADE HEALTH News Delivered to You Automatically Sign up to receive the latest news and ratings for MEDS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MEDS vs. The Competition Export to ExcelMetricTRxADE HEALTHDrugs, proprietaries, & sundries IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.66M$19.77B$5.15B$9.08BDividend YieldN/A1.52%5.12%4.25%P/E RatioN/A10.7687.0217.19Price / Sales1.438.901,122.32117.12Price / CashN/A12.2743.2337.85Price / Book16.8413.334.794.78Net Income-$17.84M$862.89M$120.55M$225.60M7 Day Performance-2.57%-4.91%-1.46%-1.36%1 Month Performance0.53%-8.77%13.76%0.20%1 Year Performance53.34%-5.72%28.69%15.30% TRxADE HEALTH Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MEDSTRxADE HEALTHN/A$7.58-6.8%N/A+53.4%$10.66M$7.45M0.0050Gap DownHYFMHydrofarm Holdings Group3.3155 of 5 stars$0.64-9.3%$0.70+10.2%-30.5%$29.30M$200.16M-0.50840Positive NewsSAGSAGN/A$2.80-5.1%N/AN/A$27.66MN/A0.00N/APositive NewsBANLCBL International0.8344 of 5 stars$0.84+1.3%N/A-40.7%$23.10M$435.90M0.0035Gap DownGDCGD Culture GroupN/A$1.94-6.3%N/A-31.7%$21.66M$-150,000.000.0060Positive NewsLTCHLatchN/A$0.12-0.1%N/A-78.6%$17.23M$41.36M0.00420COSMCosmos Health0.3628 of 5 stars$0.70-3.0%N/A-58.1%$16.28M$53.38M-0.29123News CoverageGap UpTAITTaitron Components1.5036 of 5 stars$2.65-1.1%N/A-23.2%$15.95M$6.11M11.6510Analyst ForecastNews CoverageGWAVGreenwave Technology Solutions0.166 of 5 stars$0.71+0.7%N/A-99.2%$15.80M$33.92M-0.0190HWHHWH InternationalN/A$0.58-14.7%N/AN/A$15.40MN/A0.00N/AGap UpEDUCEducational Development1.5433 of 5 stars$1.79-2.6%N/A+66.3%$15.38M$42.42M-5.75170Analyst Forecast Related Companies and Tools Related Companies Hydrofarm Holdings Group Competitors SAG Competitors CBL International Competitors GD Culture Group Competitors Latch Competitors Cosmos Health Competitors Taitron Components Competitors Greenwave Technology Solutions Competitors HWH International Competitors Educational Development Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MEDS) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRxADE HEALTH, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TRxADE HEALTH With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
